India  

Serum Institute of India

Indian biotechnology and biopharmaceuticals company

Serum Institute of India    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Serum Institute of India: Indian biotechnology and biopharmaceuticals company
Serum Institute of India (SII) is an Indian multinational biotechnology and biopharmaceuticals company, based in Pune. It is the world's largest manufacturer of vaccines by volume. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.

0
shares
ShareTweetSavePostSend
 

You Might Like


After Anand Mahindra, Adar Poonawalla responds to L&T chief's 90-hour work week remark: 'My wife loves staring at me'

Adar Poonawalla, CEO of the Serum Institute of India, backed Mahindra Group Chairman Anand Mahindra's call for prioritising quality over quantity in work hours
DNA - Published

1 in 3 Covaxin recipients hit by adverse events: Study

Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual..
IndiaTimes - Published

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped..
IndiaTimes - Published

Age is just a number, look at Ratan Tata, Bachchan: NCP Lok Sabha member Supriya Sule takes on Ajit Pawar

"Some people are saying that people who are senior now should give us their blessings (and retire). Why should they stop working? Ratan Tata who heads India's largest conglomerate is 86 years old...
IndiaTimes - Published

Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HC

The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..
IndiaTimes - Published

'Elderly people can...': SII's CEO Adar Poonawalla's big remark on Covid spike in India

India has recorded 12,193 fresh Covid-19 cases in 24 hours. The number of active cases climbed to 67,556.
DNA - Published

Covovax for adults to reach metros in a week: SII

Serum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..
IndiaTimes - Published

SII to restart vaccine production amid surge in Covid cases

Serum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to the increasing number of SARS-CoV-2 virus..
IndiaTimes - Published

Serum Institute of India restarts manufacturing of Covid-19 vaccine Covishield

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the..
IndiaTimes - Published

Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults


IndiaTimes - Published

India well-prepared to combat any future waves: SII CEO Adar Poonawalla amid Covid scare in China


IndiaTimes - Published

Drug panel favours nod for Covovax as Covid booster

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..
IndiaTimes - Published

Covovax may get approval as heterologous booster

The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..
IndiaTimes - Published

Covovax vaccine to get booster dose approval in 10-15 days: SII CEO Adar Poonawalla


IndiaTimes - Published

Covid situation in India better than elsewhere: SII CEO Adar Poonawalla

Serum Institute CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic. "Everyone..
IndiaTimes - Published